PCOS and Mood: What Drives the Emotional Symptoms
Updated: 3 days ago
Last reviewed: 09/02/2026
Reviewed by: Dr. Kiesa Kelly
If you have polycystic ovary syndrome and you have also been anxious, flat, or quietly not yourself for a long stretch, you have probably wondered which is driving which. Most articles answer the same way: PCOS is stressful, so of course your mood suffers. That is not wrong, but it is incomplete. The raised rates of anxiety and depression in PCOS do not disappear when researchers account for body weight. A situational explanation does not cover the finding, so this article treats PCOS and mood as a clinical picture in its own right — one that therapy can address directly.
In this article, you'll learn:
How much more common anxiety and depression are in PCOS, with the numbers
Why the association is not explained by weight or by fertility-related distress
What the mechanisms look like, and where the evidence is still thin
What the PHQ-9 and GAD-7 can and cannot tell you in PCOS
Which treatments have real evidence, and which claims to be careful with
PCOS and mood: the one-paragraph answer
Anxiety and depressive symptoms are substantially more common in people with PCOS. The best-known pooled analysis found roughly four times the odds of moderate-to-severe depressive symptoms, and roughly six-and-a-half times the odds of moderate-to-severe anxiety symptoms, compared with controls [2]. That association held when women were matched on body mass index. That detail matters most: the mood symptoms are not just a consequence of weight. Partly on that evidence, the 2023 international PCOS guideline recommends screening everyone diagnosed with PCOS for depressive and anxiety symptoms [3]. PCOS is one strand of a wider relationship between hormones and mental health, and it is among the best evidenced.
How common are anxiety and depression in PCOS?
Three beliefs come up in almost every conversation, and each changes what a person does next.
"My mood is low because my weight is up, so losing weight will fix it." In reality, the raised odds remained when women with PCOS were compared with controls matched on BMI [2]. Treating weight as the whole explanation delays care that would help now.
"Everyone with a chronic condition feels down — this is normal, not a disorder." Some frustration is an ordinary response to a hard diagnosis. But the pooled prevalence of diagnosable depressive disorders in PCOS reaches about 35 percent [4] — well beyond normal adjustment.
"My gynecologist would have picked it up." Endocrine care is usually organized around cycles, labs, and fertility. Mental-health screening is recommended but not universally delivered, and the psychiatric literature has called for better integration of PCOS awareness into mental health practice [5]. Many people have to raise it themselves.
What the prevalence research actually shows
The most-cited source is a 2017 systematic review and meta-analysis in Human Reproduction, pooling 30 cross-sectional studies across ten countries: 3,050 women with PCOS and 3,858 controls [2]. Women with PCOS had increased odds of any depressive symptoms (odds ratio 3.78, 95% confidence interval 3.03 to 4.72) and of moderate or severe depressive symptoms (OR 4.18, 95% CI 2.68 to 6.52). For anxiety, the odds were 5.62 (95% CI 3.22 to 9.80) for any symptoms and 6.55 (95% CI 2.87 to 14.93) for moderate or severe symptoms. Two caveats belong with those figures. Every included study was cross-sectional, so the design cannot tell us what came first. And the confidence intervals on the anxiety estimates are wide.
A 2024 overview in Archives of Women's Mental Health pooled ten systematic reviews and shows why published figures conflict [4]. Prevalence depends on how you measure. Diagnosable depressive disorders came out around 34.8 percent and anxiety disorders around 16.9 percent. Symptom prevalence on self-report questionnaires ranged from 41.5 percent on one anxiety scale to 69.4 percent on another.
🔬 Key takeaway: Published PCOS mood figures vary widely mainly because studies use different questionnaires and thresholds — not because the association itself is in doubt.
Who is most affected
In the same analysis, women with PCOS and concurrent depression had higher average age, BMI, hirsutism scores, and insulin resistance; those with anxiety had higher BMI, hirsutism scores, and free testosterone [2]. The authors called these links weak and said they do not explain the whole association. Having none of those features does not protect you.
Why PCOS affects mood
Hormonal and metabolic mechanisms
Several biological pathways have been proposed, and they most likely act together. Reviews of the pathogenesis name four candidates: insulin resistance, dysregulation of the hypothalamic-pituitary-adrenal axis that governs the stress response, hyperandrogenism, and chronic low-grade inflammation [6]. Inflammation and sustained stress-axis activation are already implicated in depression outside PCOS. But this is a hypothesis built on association studies, not a settled causal chain.
Hormonal sensitivity is also not uniform across the cycle. If your low mood follows a predictable luteal-phase pattern and then lifts, that points somewhere different — see how PMDD differs from ordinary premenstrual symptoms.
The distress that comes with the symptoms — and why it is not the whole story
The psychosocial load is real. Unpredictable periods, unwanted hair growth, acne, hair thinning, weight changes, and fertility uncertainty are hard to hide, and the World Health Organization notes that several carry social stigma affecting relationships, work, and belonging [1].
Now the finding that complicates the story. One study compared women with PCOS against women with other infertility diagnoses, all undergoing fertility treatment, and found no difference in anxiety or depression. Clinically relevant anxiety appeared in 33.1 percent of the PCOS group and 31.0 percent of the comparison group (adjusted odds ratio 0.99, 95% CI 0.74 to 1.31). Depression appeared in 15.5 percent versus 14.5 percent (adjusted OR 1.04, 95% CI 0.71 to 1.50) [7].
Read together, they give a truer picture than either alone. Against the general population, PCOS carries markedly higher odds of anxiety and depression, and weight does not explain the gap. Against other people facing infertility, the gap largely disappears. The situational burden carries real weight of its own.
The distinguishing pattern: the excess risk looks like a biological vulnerability that survives adjustment for weight, sitting on top of a psychosocial burden that is heaviest where symptoms are most visible. You do not need to settle which half applies to you before treating either.
🧩 Key takeaway: "It's hormonal" and "it's the stress of the symptoms" are not competing explanations. The evidence supports both, and neither changes what actually treats the mood symptoms.
What it looks like day to day
Prevalence figures are abstract. Here is what people actually describe.
You were diagnosed three years ago and the medical side is managed — routine appointments, stable labs, nobody worried. But you have stopped making plans that involve being seen. You cancel the morning of, and your reasons are getting thinner. Mornings take longer, because getting ready means decisions about your face and hair you would rather not make. You would not call yourself depressed; you would call yourself someone who got quieter.
Or the anxiety is the loud part. You have read enough about insulin resistance and long-term risk to keep a running list of what might be going wrong that nobody has caught. You have asked your doctor about most of them and been reassured, and it holds about four days.
Or it is the fertility thread. You are not trying yet, or you are, or you stopped and have not told anyone. Either way a low-grade grief sits under ordinary conversations, and a friend's pregnancy announcement takes a whole day to recover from. If you have started noting symptoms and mood to find a pattern, that instinct is good — tracking your cycle alongside your mood gives a clinician something concrete to work from.
🔋 Key takeaway: PCOS-related mood symptoms often show up as narrowing rather than classic sadness — fewer plans, more avoidance, more monitoring. That pattern is easy to explain away.
How mood symptoms get assessed alongside PCOS
What a psychological evaluation looks at
A good evaluation asks more than whether you meet criteria for depression. It asks what shape the symptoms take, how long they have lasted, and what else could account for them. With PCOS in the picture, four things get specific attention: whether the low mood is continuous or cycle-linked, whether the anxiety is generalized or focused on health, whether something physical is disrupting sleep, and whether disordered eating is part of it. The 2023 guideline flags eating disorders, body image, and quality of life as needing greater awareness in PCOS care [3]. The point of a structured psychological evaluation is a working explanation and a plan, not a label.
Questions worth asking any provider before you book:
Will you assess both depression and anxiety, or only the one I mentioned?
How do you account for PCOS symptoms — fatigue, disrupted sleep, weight change — that also count as depression symptoms on standard measures?
Will you ask about cycle timing and eating patterns, or should I raise those?
What do I receive at the end: a diagnosis, specific recommendations, or both?
If both a therapist and a prescriber are needed, how is that coordinated?
What screeners like the PHQ-9 and GAD-7 can and cannot tell you
Two brief questionnaires do most of the work in primary care and endocrine clinics. The PHQ-9 asks about nine depression symptoms over two weeks. A score of 10 or higher had a sensitivity of 88 percent and a specificity of 88 percent for major depression against a structured clinical interview, with 5, 10, 15, and 20 marking mild, moderate, moderately severe, and severe [8]. The GAD-7 does the same for anxiety: at a cut point of 10 or higher it identified 89 percent of people with generalized anxiety disorder, while correctly clearing 82 percent of those without it [9].
Here is the limitation that matters most in PCOS, and one we watch for clinically. Several PHQ-9 items ask about fatigue, sleep, appetite, and low energy — all of which can be driven by PCOS itself, by insulin resistance, or by unrelated poor sleep. A score can be pushed up by physical symptoms rather than mood, or pulled down if you have normalized fatigue enough to stop reporting it. A screener is a starting point, not a verdict.
📋 Key takeaway: Bring your screener score to the appointment, not instead of it. The number tells a clinician where to start asking; it does not close the question.
What actually helps
Evidence-based psychological and medical options
Cognitive behavioral therapy has the most direct evidence here. A meta-analysis pooling five trials found an effect size of Cohen's d = 1.02 favouring CBT over standard care for depression scores in PCOS. But the 95% confidence interval ran from 0.02 to 2.02 [10]. That interval only just excludes zero, so the true effect could be very large or barely detectable, and the authors urged caution given study quality. A later randomized trial supports the direction: 84 women received either eight weekly group CBT sessions or usual care, and the CBT group had lower depression and anxiety scores afterwards [11]. It was a single unblinded trial with self-report outcomes.
A 2026 network meta-analysis pooled 25 randomized trials covering 1,453 women with PCOS [12]. Emotion-focused therapy and peer support ranked highest for reducing anxiety and depression, with mindfulness-based stress management also showing benefit. Metformin, widely prescribed for the metabolic side of PCOS, did not significantly outperform control for mood. The individual trials are small, so read the rankings as a direction of travel.
Decisions about oral contraceptives, insulin-sensitizing medication, antiandrogens, or antidepressants belong with your prescriber. Dr. Kelly is a clinical psychologist, not a physician, and nothing here is medication advice. What the evidence does say is that treating the endocrine picture is not a substitute for treating the mood symptoms.
💬 Key takeaway: The strongest evidence in PCOS points toward talking therapies and structured support, not toward a medication that treats the metabolic and mood sides at once.
What to be cautious of
Be wary of anything presenting weight loss as the treatment for PCOS-related depression. That the association survives BMI matching [2] is the clearest argument against the framing, and for someone already carrying body-image distress a weight-first plan can make things worse.
Be careful with supplements marketed for "PCOS mood." Some nutritional interventions did appear effective in that network meta-analysis, but in small trials. Run anything you take past your prescriber.
Finally, be cautious of content that treats PCOS mood symptoms as a lifestyle topic. A mood symptom lasting more than a couple of weeks, and affecting how you work, sleep, or relate to people, is a clinical question.
When to get evaluated
Here is a usable rule rather than a hedge. If low mood, loss of interest, or anxiety has been present most days for two weeks or longer and is changing what you do — work, sleep, relationships, leaving the house — that meets the threshold for an evaluation, however well your PCOS is managed. If the symptoms are tied to the days before your period and lift afterwards, raise the premenstrual disorders specifically, because the treatment path differs. If the low mood arrived with a life-stage change rather than a cycle, look at that too; mood changes during perimenopause can layer onto a PCOS picture and get misattributed to it. If you cannot tell which applies, that uncertainty is itself a good reason to book.
One threshold without qualification: if you are having thoughts of harming yourself, do not wait for an appointment. In the United States, call or text 988 to reach the Suicide and Crisis Lifeline at any hour. To talk through whether an evaluation makes sense for you, get in touch with our team.
Next step: getting support
The two most common framings both leave you stuck. "It's hormonal" implies you must fix the endocrinology first. "It's just stress" implies you should manage it yourself. The evidence supports neither. It supports a mood picture with both biological and situational roots, common enough that an international guideline recommends screening everyone with the diagnosis [3], and responsive to treatment that can start now.
You do not have to know which mechanism is driving your symptoms to begin, and you do not have to wait for better labs. The question is smaller than that: are these symptoms significant enough to warrant a proper look? For most people reading this far, the answer is yes.
Navigating a women's-health or hormonal change?
Hannah Pollok works at the intersection of physical and mental health — hormones, reproductive changes, and the mood and cognitive shifts that come with them.
Frequently Asked Questions
Does PCOS cause anxiety, or do the two just tend to occur together?
We cannot say PCOS causes anxiety, but the link is strong and it is not explained by weight alone. In the largest pooled analysis, women with PCOS had roughly five to six times the odds of reporting anxiety symptoms, and the association held when women were matched on BMI. Those studies measured everything at a single point in time, so they cannot establish which came first. What they do establish is that the anxiety is common enough to be worth screening for.
Why does PCOS affect your mood?
There is no single mechanism, and the research points to several acting together. Insulin resistance, chronic low-grade inflammation, changes in the stress-hormone (HPA) axis, and androgen levels have all been proposed as biological contributors. Living with unpredictable periods, unwanted hair growth, acne, weight changes, and fertility uncertainty adds real psychological load on top of that. Both layers are legitimate, and treatment does not have to wait until we can separate them.
Can treating PCOS improve depression?
Sometimes, but treating the endocrine side is not a reliable substitute for treating the depression. A network meta-analysis of trials in PCOS found that metformin did not significantly outperform control for anxiety or depression symptoms, while psychological and support-based interventions ranked highest. That does not make medical management unimportant. It means mood symptoms usually need their own plan rather than being treated as a side effect that will clear on its own.
Is PCOS depression hormonal, or is it from the symptoms?
Current evidence says it is almost certainly both, and the split cannot be measured cleanly in an individual person. The association survives adjustment for BMI, which argues against the idea that it is simply a reaction to weight. At the same time, one study of women in fertility treatment found no extra anxiety or depression in those with PCOS, which suggests distress from the situation matters a great deal. Either way, the treatment options are the same.
Should I get screened for depression or anxiety if my PCOS is well managed?
Yes. The 2023 international PCOS guideline recommends screening everyone with PCOS for depressive and anxiety symptoms, with repeat screening based on clinical judgement rather than a fixed schedule. Regular cycles and stable labs do not rule out mood symptoms, and mood can shift with life events, pregnancy and the postpartum period, or a change in treatment. Screening takes a few minutes and gives you a baseline to compare against later.
About the Author
Dr. Kiesa Kelly is a licensed clinical psychologist and the founder of ScienceWorks Behavioral Healthcare. Her background includes clinical training at the University of Chicago, Vanderbilt University, and the University of Wisconsin, and more than 20 years of experience in psychological assessment and evidence-based treatment. Her assessment work centres on differential diagnosis in adults — telling mood and anxiety conditions apart from the physical, hormonal, and neurodevelopmental factors that can imitate or amplify them.
Dr. Kelly's practice is telehealth-forward and serves clients throughout Tennessee, with an in-person option at our Nashville office. She reviews every clinical article published here for accuracy before it goes live. She is a doctoral-level psychologist rather than a physician and does not provide medical or medication management; those decisions stay with your prescribing clinician.
References
1. World Health Organization. Polycystic ovary syndrome (fact sheet). 22 January 2026. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome
2. Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction. 2017;32(5):1075-1091. https://doi.org/10.1093/humrep/dex044
3. Teede HJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Human Reproduction. 2023;38(9):1655. https://academic.oup.com/humrep/article/38/9/1655/7241786
4. The prevalence and risk of anxiety and depression in polycystic ovary syndrome: an overview of systematic reviews with meta-analysis. Archives of Women's Mental Health. 2024. https://doi.org/10.1007/s00737-024-01526-1
5. Standeven LR, Ho A, Hantsoo L. Bridging the gap: integrating awareness of polycystic ovary syndrome into mental health practice. Focus (American Psychiatric Publishing). 2024;22(1):53-62. https://pmc.ncbi.nlm.nih.gov/articles/PMC11058927/
6. Xing L, Xu J, Wei Y, et al. Depression in polycystic ovary syndrome: focusing on pathogenesis and treatment. Frontiers in Psychiatry. 2022;13:1001484. https://pmc.ncbi.nlm.nih.gov/articles/PMC9470949/
7. Anxiety, depression, and body image among infertile women with and without polycystic ovary syndrome. Human Reproduction. 2024;39(4):784. https://academic.oup.com/humrep/article/39/4/784/7604482
8. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine. 2001;16(9):606-613. https://pmc.ncbi.nlm.nih.gov/articles/PMC1495268/
9. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine. 2006;166(10):1092-1097. https://pubmed.ncbi.nlm.nih.gov/16717171/
10. Cognitive behavioural therapy for depression in women with PCOS: systematic review and meta-analysis. Reproductive BioMedicine Online. 2022. https://pubmed.ncbi.nlm.nih.gov/35810080/
11. The effect of cognitive behavioral therapy on depression and anxiety of women with polycystic ovary syndrome: a randomized controlled trial. BMC Psychiatry. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10174601/
12. Tan Z, Li Y, Liu M, et al. A network meta-analysis of interventions for anxiety and depression in PCOS. PeerJ. 2026. https://doi.org/10.7717/peerj.20744
Disclaimer
This article is for informational purposes only and is not a substitute for individualized medical or psychological advice, diagnosis, or treatment. Reading it does not create a clinician-patient relationship. Decisions about medication, including hormonal treatment and antidepressants, should be made with a qualified prescribing clinician. If you are in crisis or thinking about harming yourself, call or text 988 in the United States, or contact your local emergency services.